Symyx has released the Symyx Direct 7.0 data cartridge, a one-stop solution for registering, searching and retrieving chemical and biological entities stored in relational databases
Symyx has released All New Discovery Gate, a powerful portal for accessing a wealth of scientific information through the web
Symyx Technologies has released Isentris 3.2, its decision support system that enables scientists to explore, compare and report on information spanning multiple experiments captured in ELNs, LIMS, the Symyx Lab Execution and Analysis (LEA) software suite, and other information management systems
ChemMobi App, from Symyx Technologies, is now available for free via Apple's App Store, providing information on chemical structures, chemical properties, suppliers and other information in the Symyx databases directly on an iPhone or iPod touch
Designed for small to mid-size R&D organisations and for individuals, Symyx Isentris Personal Edition brings advanced scientific information management, exploration and sharing capabilities to scientists without requiring an enterprise deployment
Symyx has released DiscoveryGate Web Service, providing programmable access to the DiscoveryGate content platform that hosts current chemical sourcing, molecular property, synthetic methodology, bioactivity and toxicology information from Symyx and participating content providers
Symyx has released v3.2 of its Assay Explorer biological information management system that enables scientists to capture experimental data and methodologies into a central repository
Symyx has released Symyx Draw 3.1, a software package for drawing chemical structures and querying for searching, registration, and collaboration.
Symyx has released the Symyx Notebook, which is an enterprise electronic laboratory notebook (ELN) that is configurable to meet the needs of biologists and analytical chemists out-of-the-box.
New add-ins to the Symyx Draw software will allow users to calculate physical properties, generate IUPAC nomenclature, and predict NMR chemical shifts from within the chemical drawing software.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
